Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005950
Status:
TERMINATED
Last Update Posted:
2013-01-23
First Post:
2000-07-05
Brief Title:
506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkins Lymphoma or T-cell Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Angioimmunoblastic T-cell Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult T-cell LeukemiaLymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
| Splenic Marginal Zone Lymphoma |
| Waldenström Macroglobulinemia |
Keywords: